« Return to News | CROs/Service Providers

Nautic Partners acquires CRO Omnicare

Thursday, April 28, 2011 08:01 AM

Investment firm Nautic Partners has purchased the CRO Omnicare Clinical Research (CR) from its parent company Omnicare Inc., a publicly traded company that focuses primarily on providing pharmaceuticals and ancillary services to long-term care institutions.

The terms of the deal were not disclosed.

James Pusey, CEO of Omnicare CR since September 2009, said extricating the 900-employee CRO from the corporate structure of a large publicly traded company not focused on research will allow Omnicare CR to be far more agile in growing and changing to meet demands in the clinical research industry. The CRO will announce a name change later this year, he said, adding that there will be no layoffs. Instead, the company will now go into hiring mode, he said.

Pusey said Providence, R.I.-based Nautic, one of the early investors in CRO Parexel, is now majority stakeholder in Omnicare CR, but that the CRO’s leadership team also acquired a large share of the company. Omnicare CR has been preparing to be spun off from the larger Omnicare parent since the third quarter of 2010, when the parent company announced it wanted to reallocate its investment costs, said Pusey.

Omnicare CR—which Pusey said is debt-free and brings in $100 million in annual revenue and currently boasts $160 million in backlog—was founded in 1985 as Biopharm. Along two other small CROs, it was bought by Covington, KY-based Omnicare in the late 1990s.

-- Suz Redfearn

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.